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Recent  advances  in  cell  hybridization  techniques  have  permitted  the  fusion  of 
functional  T  cell  subpopulations  with  tumor cells to yield stable T  cell hybridomas 
(1-9).  Such  hybrids  immortalize  the  biological  activity  of an  individual  cell  and 
permit analysis of monoclonal T  cell-derived helper  (5) and suppression  factors (2, 4, 
6, 9,  10). The preparation  of monoclonal T  cell hybridomas and isolation of biologi- 
cally active factors derived from monoclonal hybridoma lines can provide a  means of 
dissecting interacting T  cell subsets that exist within heterogeneous T  cell populations. 
Such an approach  permits a  more precise understanding  of the mechanism of T  cell 
interactions. 
Immune suppression  is one such T  cell-mediated  activity in which  multiple T  cell 
populations  and soluble factors are required  (11). Although  initial characterization  of 
the various suppressor T  cell populations  (Ts) 1 has been possible with heterogeneous 
Ts populations,  it  remains difficult  to analyze the contributions  of individual  T  cell 
subsets  and  to  insure  that  a  single  subset  instead  of a  mixture  of subsets  is  being 
studied.  Furthermore,  the  quantities  of cells  or  factors obtained  from  conventional 
cell preparations  are often insufficient  for detailed  analysis. Thus,  the establishment 
of monoclonal  T  cell hybrids with specific suppressor function  provides an ideal tool 
for the characterization  of the distinct suppressor cell subsets, their products, and their 
interactions. 
Regulation  of the immune  response to the hapten  4-hydroxy-3-nitrophenyl  acetyl 
(NP)  has been extensively characterized  (12-16).  Previous studies using conventional 
analysis and monoclonal T  cell hybridomas have revealed that  in the NP suppressor 
cell pathway at least three distinct  subsets of T  cells are required  for suppression  (13, 
14).  The  first  set  of Ts,  termed  Tsx,  are  induced  by  antigen,  bear  idiotypic  (Id  +) 
receptors, and can function early in the immune response (10,  12). These Tsl cells, or 
a  factor produced  by these  cells, can  induce  a  second  set of Ts, termed Ts2  (10,  13, 
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14).  The  Ts2  cells  bear  anti-idiotypic receptors  and  function  late  in  the  immune 
response (13-15). This Ts2 cell population or a soluble factor derived from it activates 
an antigen-primed Ts3 population that is thought  to provide still another suppressor 
signal (i 4). 
The Tsn population was first described by Sy et al. (17) in antigen-primed animals. 
Further  analysis  involving  the  NP  system  as  well  as  the  p-azobenezenearsonate 
suppressor system has shown  that the Ts3 population possessed idiotypic, Lyt-2, and 
I-J determinants (14,  18). 2 In addition, the induction of functional Ts3 cells is sensitive 
to cyclophosphamide (14,  17). Despite these results, the exact mechanism by which a 
Ts3 population manifests immune suppression as well as the nature of the Ts3-derived 
factor remained unknown. 
To obtain a  better understanding of the precise nature and function of Ts~ cells, we 
prepared T  cell hybridomas that  corresponded  to  the Ts3 population.  In  this com- 
munication we characterize the biologically active suppressor factors (TsF~) produced 
by  these  hybridoma  cells and  compare  these  factors  with  previously characterized 
NP-specific TsF1 and TsFe factors. 
Materials  and  Methods 
Mice.  All mice were either purchased from The Jackson Laboratory, Bar Harbor, Maine, 
or were bred in the animal facilities at Harvard Medical School, Boston, Mass. Mice were used 
at 3-12 mo of age and were maintained on laboratory chow and acidified, clorinated water ad 
lib. 
Antigens.  NP-O-Succinimide (NP-O-Su)  was purchased  from  Bioseareh Co.,  San  Rafael, 
Calif. Dimethylsulfoxide (DMSO) was purchased from Fisher Scientific Co., Pittsburgh, Pa. 
2,4-dinitro-l-fluorobenzene (DNFB)  and  keyhole limpet hemocyanin  (KLH)  were obtained 
from Sigma Chemical Co., St. Louis, Mo. 
Antisera.  Both B10.A(3R) anti-B10.A(5R) (anti-I-J  k) and B10.A(5R) anti-B10.A(3R) (anti- 
I-J  b) were produced by immunization with spleen and lymph node cells, as described elsewhere 
(4). Both monoclonal anti-Thy 1.1 and Thy-1.2 antibodies were ~urchased from New England 
Nuclear,  Boston,  Mass.  Guinea  pig  anti-CGAT  and  anti-NP  anti-idiotype antisera  were 
prepared as detailed elsewhere (12,  19). The characterization of these reagents that  detect a 
common idiotype on anti-GAT and anti-NP antibodies, respectively, was described previously 
(4). 
Preparation of Tsa CeUsfrom Antigen Plates.  The methods for the preparation and enrichment 
of NP-binding T cells were described in detail elsewhere (12). 2 In brief, 5 ×  107 regional lymph 
node or spleen cells from CKB(H-2  k, Igh-1  b) and C57BL/6  (H-2  ~, Igh-I  ~) mice, which were 
immunized  subcutaneously  with  2  mg  NP-O-Su  or with  100  /~g NP-KLH  i.p.  in  Maalox 
Perlussis (15), were added to purified anti-mouse immunoglobulin (RAMG)-coated petri dishes 
to remove B  cells. The  nonadherent  T  cells were  incubated on  NP-bovine serum  albumin- 
coated petri dishes for 45 min at room temperature. Nonadherent cells were removed by gentle 
swirling, and the plates were placed on ice for 20 min. The antigen-binding cells were collected 
from the plate by gentle pipetting and used as the source of Ts3 cells. 
Hybridization and Screening of Ts3 Hybridoma Lines.  Tsa-enriched CKB or C57BL/6 lymphocytes 
were hybridized with BW5147 T  lymphoma cells. The polyethylene glycol-mediated hybrid- 
izing method was exactly the same as previously reported (4). The hybridized Ts~ candidates 
were screened using a  cytotoxicity test  (4) with allele-specific anli-I-J and anti-NP  ~' antisera. 
Three  fusions were performed;  the CKB-Ts3-3 and  CKB-Ts:~-9  lines were derived from one 
fusion using CKB NP-O-Su-primed lymph node cells. The B6-Ts3-2 line was similarly derived 
from a  fusion between NP-O-Su-primed lymph node cells from C57BL/6 mice and BW5147 
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tumor cells. The B6-Ts3-19 line was obtained from a third hlsion using antigen-adherent splenic 
T  cells from an NP-KLH-primed C57BL/6 mouse. In addition, the B6-Tsa-8 hybridoma line 
was derived from still another fusion in which we were screening for Tsz hybrids (Minami and 
Okuda, unpublished observations). All the Tsa hybrids were  periodically passaged over the 
antigen-coated plates, and the idiotype-adherent cells were used to maintain the cell lines. The 
B6-Tsa-2, CKB-Ts3-3,  and CKB-Ts3-9 hybridoma lines were cloned by limiting dilution; l0 of 
the 11 clones tested had the same phenotype and suppressive activity as the parental line, but 
one CKB-Tsa-3 clone lacked functional activity. 
All of the hybridomas were cultured in RPMI 1640 containing 8% fetal calf serum and 0.01 
M Hepes buffer. The suppressor factors used in the present experiment were collected from the 
cultured supernatants of cells  at  an approximate density of 7  ×  105 cells/ml in the  above 
medium. 
Adsorption and Elution of TsF.  The methods of absorption and elution of TsF using protein- 
conjugated Sepharose-4B  columns were described in detail previously (4). 
Assay for Suppressive Activity of TsF on NP-mediated Cutaneous Sensitivity (CS)  Responses.  The 
assay  for NP-specific  CS responses  was described elsewhere  (10, 14). Briefly, each animal was 
primed subcutaneously with  2  mg of NP-O-Su in DMSO.  Unless indicated otherwise,  the 
hybridoma factors  were  tested  in the effector  phase, 5 or 6 d  after priming. 0.4  ml of each 
hybridoma supernatant or BW5147 control supernatant was injected i.v. on the day before and 
the day of antigen challenge. 6 d after immunization, mice were challenged in the left footpad 
with 0.025 ml phosphate-buffered saline (PBS) solution containing  30 p,g of NP-O-Su (prepared 
by mixing 25 ~1  of a  2%  NP-O-Su/DMSO solution in 0.4  ml  PBS).  Footpad swelling  3 was 
measured 24 h after challenge. Swelling was determined as the difference, in units of 10-'  cm, 
between the left and right footpad thickness. 
Functional Analysis of TsF~ and TsFa Factors in Cyctophosphamide-treated  Antigen-primed Mice.  Mice 
were primed subcutaneously with NP-O-Su on day 0, as described above. 24 h later, they were 
treated with an i.p. injection of either saline or 50 mg/kg cyclophosphamide in saline. On days 
5 and 6, each mouse received 0.4 ml i.v. of control BW5147  tumor supernatant or Ts2- or Tsa- 
derived factors. On day 6, mice were challenge with NP-O-Su, and CS responses were measured 
24 h later. 
DNFB Contact Sensitivity Responses.  Contact sensitivity was induced by two daily paintings 
on the shaved abdomen with 25 pl of 0.5% DNFB solution (Sigma Chemical Co.,  St.  Louis, 
Mo.)  in acetone:olive oil (4: i) (4). 6 d after the last painting, 20 p,1 of 0,2% DNFB in the same 
vehicle was applied to the left ear, and the ear swelling was measured as the difference between 
the left and right ear thicknesses. 
Double Antigen Ear Challenge.  Individual mice were immunized with either DNFB alone or 
with DNFB plus NP-O-Su, as described above. Mice were challenged in the left ear by painting 
with 0.2% DNFB, injecting  0.015 ml containing  6.0 ~g NP-O-Su (prepared by mixing 0.025 ml 
of 0.7% NP-O-Su in DMSO with 0.4 ml PBS, pH 7.7), or with both antigens. The incremental 
ear swelling was measured 24 and 48 h thereafter. The concentration and volume of NP-O-Su 
used to challenge was predetermined to elicit high specific  ear swelling and low nonspecific 
backgrounds. 
Percent Suppression.  The  percent  suppression in the  present  study was  calculated by the 
following formula: percent suppression =  100 ×  [(swelling of BW tumor supernatant-injected 
group -  swelling of TsF-injected group)/(swelling of BW tumor supernatant-injected group 
-  swelling of unprimed group)]. 
Data Analysis.  Statistical analysis of the experimental data with  respect  to controls was 
calculated using the two-tailed Student's t test. 
Results 
Screening of Hybridoma Suppressor Cells.  After fusion of antigen-adherent T  cells from 
NP-primed mice with AKR-derived BW5147 tumor cells, 320 of 2,300 wells developed 
hybridoma colonies. 260 of these 320 lines were screened by the microcytotoxicity test 
using allele-specific anti-I-J alloantisera.  26%  were  specifically  lysed  with  anti-I-J 
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anti-CGAT-anti-idiotypic antisera; 39% (21 of 54) of these lines were specifically lysed 
with anti-NP  b idiotype antisera. Supernatants from those lines that were specifically 
lysed with both anti-I-J and anti-NP  b were tested for suppressive activity by admin- 
istrating 0.4 ml of supernatant the day before and the day of antigen challenge. At 
least seven lines demonstrated significant levels of supppessive activity. Five of those 
that  demonstrated  >50%  suppressive  activity  of the  NP-O-Su  CS  response  were 
selected for further phenotyping and characterization. The five hybridoma lines that 
constitutively produced suppressor factor were B6-Tsa-2, B6-Ts3-8, B6-Tsa-19, CKB- 
Tsa-3,  and  CKB-Tsa-9.  Upon  retesting,  two  of the  lines  (B6-Tsa-8 and  B6-Ts3-19) 
demonstrated  variable  or no  reaction with  the  anti-I-J b or the  anti-NP  b idiotypic 
antisera,  although  these  hybridomas retained their ability to secrete a  biologically 
active suppressor factor (see below). It is not clear why these lines were screened as 
initially positive, but after continual culture, they appeared to lose their ability to 
express I-J and idiotypic determinants on their cell surface. Clones of each of these 
lines were also tested for the presence of I-J and idiotypic determinants, and again the 
clones appeared  to have little or no expression of these antigenic determinants.  In 
contrast, the other three lines have maintained the ability to express cell surface I-J 
and idiotype determinants. 
Specificity  of Suppressor Factors.  To test the biological activity of these presumptive 
suppressor hybridomas, we screened for the ability of culture supernatants obtained 
from cells growing at an approximate density of 7 X  105 cells/ml to suppress in vivo 
CS responses. As shown in Table I, injection of 0.4 ml of culture supernatant from the 
B6-Tsa-2, B6-Tss-19,  and  CKB-Tsa-9 cell lines specifically suppressed  NP-O-Su-in- 
TABLE  I 
Specificity of Hybridoma Suppressor Factors  * 
Source of TsF  Strain tested  TsF dilution 
Swelling response 
(X  10 -3 cm) ±  SE 
NP-O-Su 
DNFB (ear)  (footpad) 
BW5147  C57BL/6  Undiluted  27.3 ±  0.9  21.5 ±  0.6 
B6-Ts3-2  C57BL/6  Undiluted  13.0 +  0.7~  22.8 ±  1.7 
1/10  12.8 + 1.3~ 
1/100  21.0 +  1.4 
l/1,000  26.3 ±  0.9 
B6-Tsa-19  C57BL/6  Undiluted  15.5 +  0.61l:  26.4 +  2.7 
I/I0  14.8  +  I.I* 
1/100  20.8 + :.9, 
1/1,1000  27.5 ±  1.1 
BW5147  CKB  Undiluted  25.5 ±  0.5  22.8 ±  2.7 
CKB-Tsa-9  CKB  Undiluted  13.0 ±  1.4,  22.0 ±  0.7 
1/10  14.7 ±  0.9~: 
1/1oo  25.8 ± 5.6 
l/l,O00  25.8 ±  i.: 
* Groups of four to five mice were immunized with either NP-O-Su or DNFB, The day before and the day 
of antigen challenge mice were given an i.v.  injection of 0.4  ml of either control BW5147  or suppressor 
factor. The background responses of nonimmunized C57BL/6 mice were 4.1  ±  0.7  and  11.2 "4-  1.2  for 
NP-O-Su and DNFB, respectively. The background responses of CKB mice were 3.0 ±  0.4 and 2.6 +  0.7 
for NP-O-Su and DNFB, respectively. 
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duced CS responses.  The culture supernatants  demonstrated  maximum  plateau levels 
of activity  when  given  either  undiluted  or  diluted  1:10.  In  these  experiments  the 
percent of suppression  ranged  from 50-75%.  After further dilution  these materials  no 
longer demonstrated  significant  levels of suppressive activity. 
The  antigen  specificity  of these  suppressor  factors  was  initially  demonstrated  by 
their inability  to suppress  the  DNFB-induced  contact  sensitivity responses  (Table  I). 
The  NP  specificity  of the  B6-Tsa-8  and  CKB-Tsa-3  suppressor  factors  was  similarly 
established  (data  not shown). 
Although  the specificity of these suppressor  factors was demonstrated  by the above 
criteria,  it  could  still  be  argued  that  specific antigen  is  only  required  to  trigger  the 
suppressive activity, and once triggered, the suppression  would be nonspecific. Several 
examples of such  antigen-dependent  nonspecific suppression  have been  noted  in  the 
literature  (22-24).  To evaluate the latter possibility,  groups  of four to five C57BL/6 
mice were  immunized  with  either  DNFB  alone  or  DNFB  plus  NP-O-Su.  After 5  d, 
the animals  were given either control  BW5147  supernatants  or culture supernatants 
from  B6-Tsa-2  or  B6-Ta-19  cells.  The  mice  were  then  challenged  in  the  left  ear  by 
painting  with  DNFB,  injecting 7.0 #g NP-O-Su  in  15/.tl  PBS  (pH  7.7),  or with  both 
antigens.  The  incremental  ear  swelling was  measured  at  24  and  48  h.  The  data  in 
Table II verify specificity of the B6-Tsa-2 and the B6-Tsa-19 factors. Thus, these latter 
factors  fail  to  suppress  ear  swelling  responses  induced  and  elicited  with  DNFB  or 
responses  induced with NP-O-Su  plus DNFB  priming and elicited with DNFB  alone. 
However,  the  activity of the  B6-Tsa-2  and  B6-Ts3-19-derived  factors  was  confirmed 
by their ability to suppress  ear swelling responses  in mice primed with both  NP-O-Su 
plus  DNFB  and  challenged  with  NP-O-Su  alone.  To  determine  whether  these 
TABLE  II 
Specificity of Suppressor  Factor in Doubly-Primed or Challenged Recipients * 
Antigen priming  TsF source  Antigen challenge  Ear swelling (× 10  -3 cm) ±  SE 
24 h  48 h 
DNFB  BW5147  DNFB  13.0 -  1.7  13.3 ±  1.0 
DNFB  B6-Ts3-2  DNFB  16.0 ±  3.0  16.0 _  2.3 
DNFB  B6-Tsa-19  DNFB  I1.0 +  1.8  14.0 ±  1,2 
--  BW5147  DNFB  1.0 +  0.4  2.0 +  0.4 
NP-O-Su +  DNFB  BW5147  DNFB  15.0 ± 0.7  13.0 ±  1.8 
NP-O-Su +  DNFB  B6-Ts3-2  DNFB  13.0 +  1.4  12.5 ±  1.7 
NP-O-Su +  DNFB  B6-Tsz-19  DNFB  16.0 _+ 2.7  15.0 ±  1.1 
--  BW5147  DNFB  1.0 ± 0.4  2.0 ± 0.4 
NP-O-Su +  DNFB  BW5147  NP-O-Su  18.5 ±  1.2  16.5 ±  1.3 
NP-O-Su +  DNFB  B6-Ts3-2  NP-O-Su  8.3 ± 0.%  7.8 ±  1.4:~ 
NP-O-Su +  DNFB  B6-Ts3-19  NP-O-Su  8.3 ±  2.7:~  8.3 ±  1.1~: 
--  BW5147  NP-O-Su  8.3 ±  1.9  4.3 ±  0.8 
DNFB  BW547  NP-O-Su +  DNFB  16.5 +  1.2  12.8 ±  1.0 
DNFB  B6-Ts:r2  NP-O-Su +  DNFB  19.3 ±  2.5  12.8 ±  1.4 
DNFB  B6-Ts3-19  NP-O-Su +  DNFB  t9.0 ±  2.0  t3.8 ±  1.7 
--  BW5147  NP-O-Su +  DNFB  10.5 ±  1.2  6.5 ±  1.0 
* Groups of four to five mice were  primed with  DNFB alone or with  DNFB and  NP-O-Su.  5 and  6 d 
thereafter, they were given TsF or control factors,  followed by ear challenge with DNFB, NP-O-Su, or 
both antigens.  The specific ear swelling responses were measured  24 and 48 h after challenge.  The data 
are expressed as the increment of ear swelling (× 1() -:~ cm) +  SE. 
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suppressor factors would nonspecifically suppress DNFB responses when the animals 
were  challenged  with  both  NP-O-Su  plus  DNFB,  another  series  of animals  were 
tested.  As shown  in  Table II, the  presence of NP-O-Su  in  the challenge  site is  not 
sufficient  to  suppress  DNFB-induced  contact  sensitivity  responses.  Thus,  the  data 
demonstrate that these hybridoma-derived suppressor factors are antigen specific. 
Effector-Phase  Suppression.  To compare this series of NP-specific suppressor factors 
with the previously characterized Tsl- and Ts2-derived hybridoma factors, we deter- 
mined when in the course of the immune response the various factors were active. 0.4 
ml of factor was injected i.v. either on the day of and the day after antigen priming 
(induction phase) or the day before and the day of antigen challenge (effector phase). 
As  previously reported  (10),  the  B6-Tsl-29- and  CKB-Tsl-17-derived control TsF1 
factors only demonstrated suppressive activity when administered during the induc- 
tion phase of the immune response (Table III). In contrast, the previously character- 
ized B6-Ts2-28-derived TsF2 factor (20)  and the five new hybridoma factors were only 
active when administered in the effector phase of the NP-O-Su CS response (Table 
III). 
Genetic Restrictions of Hybridoma Suppressor Factors.  To further compare this new series 
of  hybridoma  suppressor  factors  with  those  previously characterized,  the  genetic 
restrictions  of  this  new  series  of  factors  was  determined  in  comparison  with  the 
monoclonal control Tsl- and Ts2-derived factors.  The Tsl  factor was  administered 
during the induction phase of the immune response, whereas the Ts2 and the new 
series of suppressor factors were administered during the effector phase. As shown in 
Table IV and in confirmation of previous data  (10,  20),  the C57BL/6-derived TSl 
factor from the B6-Ts1-29 cells suppressed NP-specific CS responses in both syngeneic 
TABLE III 
Comparison of the Ability of TsF to Suppress CS Responses m the Induction 
vs. Effector Phase 
NP-O-Su  TsF source  Strain tested  primed 
NP-O-Su-induced swelling 
(× 10  -3 cm) ± SE 
Induction  Effector 
phase  phase 
None  C57BL/6  +  36.4:1:1.4  36.5 ±  1.4 
B6-Tsl-29  C57BL/6  +  18.3:1:1.75  35.3 -t- 2.9 
B6-Ts2-28  C57BL/6  +  34.9 zl: 1.3  23.5 ±  1.55 
B6-Tsa-2  C57BL/6  +  39.5 ± 4.2  13.8 + 2.2:~ 
B6-Ts3-8  C57BL/6  +  36.0 + 5.4  21.1 ± 2.1:[: 
B6-Ts3-19  C57BL/6  +  36.8 ± 3.3  19.5 ± 3.0:[: 
None  C57BL/6  -  10.6 ± 2.6  10.6 ~ 2.6 
None  B10.A  +  34.6 ± 3.6  34.6 ± 3.6 
CKB-TsI-17  BI0.A  +  12.8 ±  1.85  30.4 ± 2.9 
CKB-Ts3-3  B10.A  +  31.5:1:2.6  18.3 ±  1.75 
CKB-Ts3-9  B10.A  +  32.3 ±  1.3  16.8:1:2.05 
None  B10.A  -  8.7 ±  1.2  8.7 -e 1.2 
* Groups of four to five mice were immunized with NP-O-Su and were given 
TsF either at  the  time of antigen priming  (induction phase) or antigen 
challenge (effector phase). The results with the control TsF1 and TsF2 factors 
were obtained  from separate experiments. The data  were normalized for 
presentation. 
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TABLr IV 
Genetic Restrictions of Suppressor Factors * 
NP-O-Su 
TsF source  priming 
Footpad swelling (×  10  -a cm) in recipient strains ±  SE 
C57BL/6  B6.Igh  e  B 10.WB  CWB  C3H.SW 
(H-2  b  , Igh  b  )  (H-2  b  , Igh  ~)  (H-2  j , Igh  b  )  (H-2  b  , Igh  b  )  (H-2  b  , IgH  j  ) 
BW5147  +  24.8±  1.9  17.4:t:  1.1  20.8±0.7  31.2 ±  3.1  29.8±2.3 
B6-Tsr29  +  10.7 ±  1.3~  NT§  9.7 ±  1.0~  NT  NT 
B6-Ts~-28  +  12.6 ±  1.9z~  16.5 ±  1.9  19.3 ±  0.9  NT  NT 
B6-Tsa-2  +  12.2 ±  0.7~:  18.8 ±  0.3  21.5 ±  0.4  12.3 ±  1.9:[:  29.5 ±  1.0 
B6-Tsa-8  +  14.8+  1.2~  NT  22.5±2.1  19.5 ±  2.9z~  26.0±  1.5 
B6-Tsa-19  +  9. l  ±  3.1~:  NT  25.1  ±  3.4  14.8 ±  2.6:]:  32.5 ±  4.2 
BW5147  -  5.2 ±  1.0  3.5 ±  1.2  5.5 ±  1.3  6.3 ±  1.3  7.8 ±  1.9 
* Groups of four to five mice were immunized with NP-O-Su and were given TsF during the induction 
(TsFi)  or effector phase of the immune response. The data are expressed as the increment of footpad 
swelling ±  SE in units of 10  -a cm. 
Significant suppression, P <  0.05. 
§ Not tested. 
C57BL/6 (H-2 b, Igh  b) and H-2-incompatible B10.WB (H-2  j, Igh  b) mice. In contrast, 
the C57BL/6-derived B6-Tsz-28  factor would not suppress NP-specific CS responses 
in H-2-incompatible B 10.WB mice. Furthermore, the Ts2 factor also failed to suppress 
CS responses in Igh congenic B6.Igh  e (H-2  b, Igh  e) mice. Similarly, the B6-Tsa-2,  B6- 
Ts3-8, and B6-Tsa-19  factors also failed to suppress NP responses in H-2-incompatible 
B 10.WB mice or in Igh-incompatible B6.Igh  e and C3H.SW (H-2  b, Igh  j) mice. Because 
the C57BL/6  and  B6.Igh  ~ strains  as well  as  the C3H.SW  and CWB  (H-2  b,  Igh  b) 
strains are both congenic with respect to the Igh complex, the data suggest that the 
Tsz and the presumed Ts3-derived factors are restricted by genes in both the Igh and 
H-2 complexes. It should be noted that the B6-Tsa-2  cells that produced this factor 
were a  cloned subline. In another series  of experiments, factors derived from cloned 
sublines of CKB-Tsa-3 and CKB-Tsa-9 cells were also shown to be both H-2 and Igh 
restricted  (data  not  shown).  Variations  in  the  magnitude  of the  NP-specific  CS 
responses in different inbred strains were noted in the data shown in Table IV. This 
variation  appears  to  correlate  with  the  age  of the  recipient  mice;  older  animals 
generally yield larger footpad swelling responses (unpublished observations). 
To  determine which  subregion  of the  H-2  complex  restricted  suppressor  factor 
activity,  control  B6-Ts2-28-derived  TsF2,  which  was  previously  shown  to  be  I-J  b 
restricted  (20),  and  the  new  series  of  hybridoma-derived  factors  were  tested  in 
B 10.MBR (K  b, I  k, S  k, Dq), B 10.A(3R)  (K b, IA  b, IB  b, IJ  b, IE  k, IC  d, S  a, Da), B 10.A(4R) 
(K  k, IA  k, IB  b, IJ  b, IC b, S b, ob), and B 10.A(5R)  (K  b, IA  b, IB b, IJ k, IE  k, IC  d, S  d, D d) NP- 
O-Su-primed recipients. The combined results of two independent experiments were 
normalized and presented in Table V. The C57BL/6 (H-2b)-derived B6-Ts2-28,  B6- 
Tz-2,  and  B6-Tsz-19  factors suppress  NP  responses  in  H-2K-,  I-A-,  I-B-,  and  I-J- 
compatible B 10.A(3R)  and I-B-, I-J-, I-E-, I-C-, S-, and H-2D-compatible B 10.A(4R) 
mice but  failed to  suppress  H-2K-compatible  B I0.MBR or  H-2K-,  I-A-,  and  I-B- 
compatible  B10.A(5R)  recipients.  In  contrast,  the CKB(H-2k)-derived  factors  that 
were derived from cloned CKB-Tsz-3 and CKB-Tsz-9 sublines suppressed I-A-, I-B-, 
I-J-, I-E-, I-C-, and S-compatible BI0.MBR and I-J- and I-E-compatible BI0.A(5R) 
recipients but failed to suppress I-E-compatible BI0.A(3R)  or H-2K- and I-A-corn- K. OKUDA,  M.  MINAMI, S.  FURUSAWA, AND M.  E.  DORF  1845 
TABLE V 
Intra-H-2 Mapping of TsF~ Restriction* 
NP-O-Su 
Source of TsF3  Priming 
Footpad swelling (X 10  -3 cm) in recipient strains 2: SE 
BI0.MBR  B10.A(3R)  B10.A(4R)  B 10.A(5R) 
(bkkkkkkc  0  (bbbbkddd)  (kkbbbbbb)  (bbbkkddd) 
BW5147  +  36.5 2:3.6  3.8 2:1.4  36.2 2:2.0  31.6 2:1.6 
B6-Ts2-28  +  39.9 2:5.2  20.6 2:3.05  19.3 2: 2.3~:  28.0 2:2.1 
B6-Ts3-2  +  34.5 + 2.1  16.8 2:3.35  23.0 :t: 2.0:~  31.0 2:8.7 
B6-Ts3-19  +  39.8 2:2.3  24.5 2:3.05  20.5 2: 3.2:~  38.0 2:4.5 
CKB-Ts3-3  +  21.2 zt: 2.6:~  36.3 2:1.7  32.8 2:2.1  25.0 2: 1.3:~ 
CKB-Tss-9  +  23.4 2: 2,3:~  36.5 2:1.4  31.5 2:2.7  21.0 2: 2.5:~ 
BW5147  -  8.8 :t: 2.2  8.5 2:2.2  11.3 2:2.3  12.3 :!: 1.3 
* Groups of four to five mice were immunized with NP-O-Su and were given TsF during the effector phase 
of the CS response. The data are expressed as the increment of footpad swelling  2: SE in units of 10  -3 era. 
The alleles at the H-2K, IA, ]B, I  J, IE, IC, S, and H-2D regions of the recipient strains are indicated in 
parentheses. The results with the control TsF2 factors were obtained from separate experiments, and the 
data were normalized for presentation. 
:~ Significant suppression,  P < 0.005. 
TABLE VI 
Immunochemical Characterization of Hybridoma Suppressor Factors* 
Immuno-  B6-Ts1-29  B6-Ts2-28  B6-Ts3-2  B6-Tsn-8  B6-Ts3-19  CKB-Ts3-9 
adsorbent 
columns  Unbound  Eluate  Unbound  Eluate  Unbound  Eluate  Unbound  Eluate  Unbound  Eluate  Unbound  Eluate 
None  83  5  67  65  69  68 
Anti-l-J  k  89  -  17  63  19  68  -9  57  4  56  5  0  58 
Anti-IJ  h  0  72  10  77  -9  87  6  64  11  73  50  3 
Anti-lg  89  I 1  75  17  75  5  65  -  13  45  7  52  -8 
Anti-NP  b  22  83  67  12  27  81  2 [  63  4  83  -3  62 
NP  b  71  -I  9  86  92  5  69  9  74  I0  59  6. 
NP-KLH  17  69  61  I 0  22  94  -5  70  0  42  -  1  56 
* Hybridoma-derived TsF containing supernatant fluids  were adsorbed onto various columns and the unbound and acld-eluted fractions were tested for 
suppressive  activity in  either C57B1/6 or  BI0.BR recipients. The results using the control  B6-Tsl-'29  and  B6-Ts2-28-derived  TsF were previously 
published  (20). The data are expressed as the percent suppression  of the NP-CLSu CS response  compared with BW5147 supernatant controls.  Less 
than 3017~, suppression  is not significant. 
patible B10.A(4R) recipients. Thus, it appears that I-J homology is required between 
both the factor donor and recipient strains for TsF2 and TsFa functional activity. 
Immunochemical Characterization of Suppresor Factors.  In further attempts to distinguish 
the Ts2- and the presumed Tsa-derived factors from each other and from the previously 
described TsF1 factors, selected factors were passed over a series of immunoadsorbent 
columns. The  suppressive  activity of the  C57BL/6(H-2b)-derived factors  could  be 
depleted  by  passage  over  anti-IJ  b  columns but  not  anti-IJ  k  columns.  In  contrast, 
CKB-Ts3-9 (H-2k)-derived factor was specifically adsorbed by anti-IJ  k columns. The 
suppressive activity could be recovered by acid elution (Table VI). The suppressive 
activity of the Tsl, Ts2, and the new series of hybridoma factors were not adsorbed by 
polyvalent guinea pig anti-immunoglobulin  columns that were reactive with #,  7z, 
72a, yZb, ~, and ~  chains. However, the Tsl and the new series of hybridoma factors 
were  adsorbed  by  guinea pig  anti-idiotype columns and  NP-KLH  columns. This 
contrasts  the  results  obtained with  B6-Ts2-28-derived factor,  which  could  not  be 
adsorbed by either anti-idiotype or NP-KLH immunoabsorbent columns (Table VI 
and reference 20). However, B6-Ts2-28-derived TsF2 lacks an NP binding site and in 1846  CHARACTERIZATION OF TsF3 SUPPRESSOR  FACTOR 
contrast  to  the  other  factors  could  be  depleted  on  NP b  idiotype  columns.  The 
specificity  of adsorption  was  controlled  by  demonstrating  that  suppressive  activity 
could be recovered by acid elution from the appropriate  columns.  Thus, we conclude 
that  this  new  series  of hybridoma  factors  bear  I-J  and  idiotypic  determinants  and 
have a  specific receptor  for NP  hapten.  These  features  distinguish  the  new series of 
effector-phase  hybridoma-derived  suppressor  factors  from  the  previously  described 
TsF2 suppressor  factors  (20). 
Activity  of TsF in  Cydophosphamide-treated  Recipients.  Previous reports  (14,  17)  dem- 
onstrated  that  the precursor  Tsa cells were sensitive to cyclophosphamide  treatment. 
To  further  compare  Tsz-  and  Tsa-derived  suppressor  factors,  hybridoma  TsF~  and 
TsFa were administered  to animals that were treated with 50 mg/kg  of cyclophospha- 
mide  1  d  after  antigen  priming.  The  hybridoma-derived  suppressor  factors  were 
administered  during  the effector phase  of the immune  response.  As shown  in Table 
VII, cyclophosphamide  pretreatment  does not alter the magnitude  of the NP-specific 
CS response.  Furthermore,  B6-Tsz-28-derived  factor failed to suppress  cyclophospha- 
mide-treated mice, whereas the B6-Ta-8- and B6-Tsa-19-derived factors were active in 
cyclophosphamide-treated  recipients.  Similar  results  were  noted  with  CKB-derived 
TsF2  and  TsFa  factors  (data  not  shown).  These  results  suggest  that  TsF~ activates  a 
cyclophosphamide-sensitive  Tsa  target  population  and  that  TsF3  can  replace  the 
requirement  for this cyclophosphamide-sensitive  antigen-primed  suppressor cell pop- 
ulation. 
Discussion 
This report characterizes a  new series of suppressor cell hybridoma  lines. Five T  cell 
hybridoma  lines have been characterized.  These new hybridomas  differ from the two 
TABLE  VII 
Ability of TsF to Suppress  Cydophosphamide-pretreated  Recipients * 
Experiment  TsF source  NP-O-Su  Cyclophos-  Footpad swell- 
phamide  ing (× 10 -a 
number  priming  treatment  cm) ±  SE 
1  BW5147  +  -  24.0 ±  1.6 
BW5147  +  +  23.6 ± 0.7 
B6-Tsz-28  +  -  12.3 ±  1.4~: 
B6-Tsz-28  +  +  23.2 ±  1.6 
B6-Ts~-2  +  -  10.8 ±  1.9~: 
B6-Tsz-2  +  +  10.8 ±  1.1:~ 
B6-Tsa-8  +  -  11.0 ±  1.5:~ 
B6-Tss-8  +  +  13.6 zl: 1.0:~ 
BW5147  -  -  5.8 ±  1.1 
2  BW5147  +  -  31.0 ±  1.0 
BW5147  +  +  29.3 ±  2.1 
B6-Tse-28  +  -  14.8 ±  1.0:~ 
B6-Ts~-28  +  +  31.3 ±  1.8 
B6-Ts3-19  .+  -  18.8 ±  1.4:~ 
B6-Tsa-19  +  +  21.8 ±  1.4~: 
None  -  -  11.6 -'r 1.2 
* Groups of four to five mice were immunized with NP-O-Su, and 24 h later 
some groups were given 50 mg/kg cyclophosphamide i.p. During the effector 
phase of the CS response the animals were given 0.4 ml of TsF/d. The data 
are expressed as the increment of footpad swelling ±  SE in units of 10  -3 cm. 
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other types of NP-specific suppressor T  cell hybridoma lines previously characterized 
(10,  20).  First,  the cells used  for fusion are primarily derived from mice that  have 
been immunized with either NP-O-Su or NP-KLH. In the past, we have used spleen 
cells from animals  that  were tolerized by intravenously administering NP-coupled 
syngeneic cells. However, we obtained one Ts3 hybridoma line from spleen cells of 
mice that were tolerized with NP-coupled syngeneic cells. Although this demonstrates 
that Tsn cells were also present in tolerized animals, the frequency of such cells must 
be  very low.  Thus,  only one such  hybridoma  line  has  been  discovered  after the 
screening of several thousand hybridomas from animals that were tolerized with NP- 
coupled syngeneic cells. 
This new series ofT cell hybridomas bear allele-specific I-J cell surface determinants 
and  generally  bear  Npb-related  idiotypic  determinants.  The  presence  of Thy-l.2 
marker on  most  of the  hybridoma lines  and  the  Lyt-2.2 marker on  the B6-Tss-19 
hybridoma (data not shown) is consistent with the previously reported phenotype of 
the  Ts3  population.  In  a  few  cases,  phenotyping  for the  Lyt-2.2 marker  was  not 
possible because two different monoclonal reagents gave disparate results. 
The suppressor factors derived from these hybridoma cell lines were also character- 
ized. The TsFs suppressor factors differed from the previously characterized TsF1 and 
TsF2 factors. TsF3  factor acts  during the effector phase  in  contrast  to TsF1  factor, 
which is active only during the induction phase of the CS response. It is not clear why 
TsF2 or TsF3  factors function only during  the  effector phase  and  do not  mediate 
suppression when given during the induction phase of the CS response. One possibility 
is that these materials have a very short biological half-life. Alternatively, the timing 
of factor administration with respect to the occurrence of an appropriately differen- 
tiated target cell population might be critical. 
The antigenic properties of TsFs were determined by passing these factors over a 
series of immunoadsorbent columns. Ysa- and Tss-derived factors had similar char- 
acteristics. First, both factors bore I-J alad NP  b idiotypic determinants and bound to 
antigen columns; all the suppressor factors lacked constant region immunoglobulin 
determinants. As reported elsewhere (20), TsF2 factor bound to idiotype columns and 
apparently possessed an anti-idiotypic receptor (Table VI). 
To further distinguish TsF3 factor than TsF1 and TsF2 factors, the genetics of factor 
activity were analyzed. TsFa factor, like TsF~ factor, only suppressed strains that were 
matched at both the Igh and H-2 gene complexes (Table IV). In contrast, TsF1 factor 
lacks at least H-2 i'estrictions, but as described elsewhere (10), is pseudo-restricted by 
genes  in  the  Igh  complex.  To  further distinguish  the  TsF3  factors  from  the  TsF2 
effector-phase factors, the activity of these factors was tested in animals that had been 
treated  with  cyclophosphamide.  TsFz factor failed to  suppress  cyclophosphamide- 
treated  mice, whereas  TsFa  factor retained  its  activity in  animals  pretreated  with 
cyclophosphamide  (Table VII).  Finally, the target cells of each type of suppressor 
factor are distinct. Thus, TsF1 functions by inducing a Ts2 population, whereas Ts2 
factor appears to trigger a cyclophosphamide-sensitive Ts3 cell population. The target 
cell  of the  TsFs  factor  is  unknown.  Table  VIII  summarizes  the  similarities  and 
differences between Tsl, Ts2, and Tsa cells and the factors derived from these cells. 
The literature describes many suppressor cell systems, some of which appear to be 
antigen specific (24-29), whereas others demonstrate elements of nonspecificity (21- 
23, 28). The NP system has been shown to be specific in this and in previous reports 1848  CHARACTERIZATION OF TsF3 SUPPRESSOR FACTOR 
TABLE  VIII 
Characteristics of NP-specific Suppressor Factors 
Properties of TsF  Phenotype of cell 
producing TsF 
Type of suppressor factor 
TsF1  TsF2  TsF3 
I-J  +  +  + 
NP  b idiotype  +  --  + 
Cell type  Tsl  Ts2  Ts3 
MHC determinants  I-J  I-J  I-J 
Igh-C determinants  None  None  None 
Igh-V determinants  NP  b  ?  NP  b 
Binding specificity  NP  NP  b idiotype  NP 
Phase of action  Induction  Effector  Effector 
Cellular target  Pre-Ts2  Tsa  ? 
Genetic restriction  None  I-J and Igh  I-J and Igh 
Activity in cyclophosphamide-  ?  None  Yes 
treated recipients 
(10, 14, 15). The experiments using animals primed or challenged with DNFB together 
with  NP-O-Su  strengthen  the conclusion  that  the suppression  mediated  in  the  NP 
system is antigen specific (Table II). The fact that TsF3 factor is Igh restricted differs 
from the observations in some suppressor cell systems (18, 22,  29). There are several 
possible explanations for these apparently disparate results. First, the systems and the 
methods  used  are  quite  different  in  the  various  suppressor  models  studied.  The 
different methods for evaluating specificity might account for the results observed. It 
is  noteworthy  that  Fresno  et  al.  (26)  have characterized  a  specific TsF3-1ike factor, 
which  upon cleavage or partial  degradation becomes antigen  nonspecific. We have 
not evaluated this possibility in our system. An alternative possibility is that there are 
several Ts3-1ike  cells, some of which  mediate nonspecifie suppression.  If the latter is 
true, we must conclude that in the NP system the antigen-specific Igh-restricted Ts3 
population appears to predominate. 
The Ts3 factors show  dual  genetic  restriction,  requiring  both I-J and  Igh region 
homolog~ for factor activity. Such findings of dual genetic restrictions are not unique 
to the NP system nor the TsF3-derived factors. Thus, Suzuki et al.  (16)  and Dietz et 
al. (30)  have recently also reported dual genetic restrictions of suppressor factors. The 
fact that Igh restrictions are observed suggests that idiotype-anti-idiotype interactions 
are  required  between  TsF3  and  its  target  cells.  Furthermore,  these  Igh restrictions 
argue  against  an  antigen-bridging  mechanism  occurring  between  the  TsF3  and  its 
target cells.  The results  imply, therefore,  that  the target of TsF3 might be an anti- 
idiotypic suppressor or helper cell population. At the present time, we are attempting 
to characterize this target population. The I-J restrictions observed with TsF3 factor 
might reflect a  requirement for an acceptor site on the target cell population that is 
required for triggering or inactivating the target cell. Alternatively, they might reflect 
a  pseudo-genetic restriction  similar to that  previously characterized  for TsF1  factors 
(10). 
The Ts3 cells described in this report constitutively secrete TsF3 factor. This suggests 
that some of the Ts3 cells are normally present in antigen-primed animals. These Ts3 
appear to be fully differentiated and might be involved in the autoregulation of the 
NP-specific  immune  response.  The  question  of how  these  Ts3  cells  are  activated K. OKUDA, M. MINAMI, S.  FURUSAWA, AND M. E. DORF  1849 
remains  unanswered.  One  possibility  is  that  a  few Ts2 cells also  exist  in  antigen- 
primed mice and these Ts2 cells release TsF2 factor that activates a small percentage 
of the Tsz population. Another possibility is that Tsz ceils might also be activated by 
other means, e.g., anti-idiotype antibody. Finally, we cannot exclude the possibility 
that in situ the Tsz cells were not actively secreting TsF8 factor but that after fusion 
with  the  BW5147  tumor  line  the  hybrids  began  to  actively secrete  TsFz  factor. 
Preliminary experiments suggest  that  antigen-primed mice possess a  population of 
mature  Ts3 cells  that  do  not  secrete TsFs  unless  activated with  TsF2  factor. This 
resting Ts3 population presumably accounts for the bulk of the Tsz cells in antigen- 
primed  mice. Thus,  the NP responses of immune animals  are not completely sup- 
pressed  until  sufficient Ts3  suppressor  cells  are  activated  to regulate  the  immune 
response. 
The characterizaton of three distinct series of suppressor factors specific for the CS 
response  to  the  NP  hapten  demonstrates  the  intricacy  of the  immunoregulatory 
pathway. The precise differences between the immunoregulatory molecules responsi- 
ble  for the communications between suppressor T  cells  is unknown.  However, the 
potential availability of large quantities of monoclonal TsFa, TsFz, and TsF3 factors 
derived from both the C57BL/6 and CKB series of hybridoma lines should permit 
molecular comparisons among these functionally distinct T  cell-derived products. 
SLlmlTlary 
Five hybridoma T  cell lines were prepared by fusion of Ts3 cells with the BW5147 
thymorna. The culture supernatants  from these T  cell hybrids contained a  factor, 
TsFa,  which  specifically  suppressed  4-hydroxy-3-nitrophenyl acetyl  hapten  (NP)- 
hapten cutaneous sensitivity responses. The properties of this new series of hybridoma 
factors was compared with those of two previously characterized types of NP-specific 
suppressor factors (TsF1 and TsF2). TsF3 activity was only observed if the factor was 
administered during the effector phases of the immune response. TsFz bears I-J and 
C57BL anti-NP antibody idiotypic determinants and has binding specificity for the 
NP  hapten.  Furthermore, TsFa does not  suppress  H-2  (I-J)-incompatible mice.  In 
addition  to this H-2 restriction, the monoclonal TsF3 factors also demonstrated an 
Igh genetic restriction. Finally, the TsF3 factors could be distinguished by their ability 
to suppress cyclophosphamide-treated recipients. 
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